Sexual dysfunction:COMPARATIVE STUDY in LNG-UID and ETO-Implant users.

G.Grazziotin¹.
¹Tancredo Neves Medical Center, Mato Grosso, Brazil

Sexual desire depends on mood and motivation to sexual intimacy as well as on hormonal factors. Previous
studies indicate that 20% to 30% of Hormonal contraception users experience a reduction in sexual desire.
The goal of the study is to compare the frequency of sexual complaints among the users of: LNG-
UID AND ETO-IMPLANT.
31 women, divide in 2 groups: 17 women LNG-DIU, 14 women ETO-implant.
Patients that have completed 12 months.

Inclusion criteria:
Women in use of Eto- Implant or LNG –DIU there is at least 3 months.
At least 18 years old, stable heterosexual relation during at least 3 months, in a heterosexual relationship,
not smokers, did not have any other psychiatric pathology.
Normal levels of FSH, LH, DHEA, TSH, Prolactin. Physiologic levels of Testosterone.
Evaluation Protocol Follow up. It was in three months intervals.
Numeral Visual Scale,. McCoy Sexual Scale, . Psychological General Well-Being Index (PGWB)
. Short Sexual Functioning Scale (SSFS) VWAG/WOG/IFSSS/2005 applied in each three months during
one year.
History and physical examination ,BMI (body mass index) , Endometrial evaluation by transvaginal
ultrasound , (3º/5º day. Endometrial measure until 5mm.) .Lab: Blood (TBC) Coagulation, Glycemia,
Triglycerides, Total cholesterol, Urea, Creatinine, TSH, FSH, LH, Prolactin, Testosterone.

RESULTS :
10 women (32,2%) were multiparous
11 (35,4%) had concurrent medical conditions; all of them in medical supervision treatment.
LNG 88% had completed 12 months.
ETO 60.8% completed 12 months. The most common reason causing the retreat need was bleeding
irregularity.
Depressive symptoms:
LNG group: Average depressive symptoms at first evaluation 17, 6%., average depressive symptoms at
3rd, 6th and 9th evaluation acres group to 21%.
ETO group: Average depressive symptoms at first evaluation 21, 4%, average depressive symptoms at
3rd, 6th and 9th evaluation acres to 26%.
Comparison: Eto implants versus LNG-UID.
LNG - IUD:
2 LNG insertions were performed under general anesthesia.
Bigger incidence of acne and breast pain.
Bigger amenorrhea indexes.
About the ability of progestin to produce negative mood 58% classified as none mood negative effects.
At 3rd, 6th and 9th evaluation average of depressive symptoms acres in the two groups.
LNG IUD group shown smaller acres percentage. (4%)
LNG IUD group shown the best performance, having less incidence in changes at sexual behavior.
When the changes happen this group had a smaller incidence in the sexual behavior negative changes as
arousal, desire's decrees ,
orgasm decrees as well.
This group also shown less number of patients complains of Sexual Wish Decreased and less desire for
sexual activities.
ETO_IMPLANT:
Higher incidence: In spotting, irregular bleeding, weight gain and migraine.
About the ability of progestin to produce negative mood 37% classified as none mood negative effects.
At 3rd, 6th and 9th evaluation average of depressive symptoms acres in both groups.
Eto-Implant group shown bigger acres on depressive symptoms percentage.
Female sexual dysfunction is a complex problem with multiple overlapping etiologies.
Hormones play an important role in healthy female sexual function
Sexual dysfunction: COMPARATIVE STUDY in LNG-UID and ETO-Implant users.
G.Grazziotin¹.
¹Tancredo Neves Medical Center, Mato Grosso, Brazil

Sexual desire depends on mood and motivation to sexual intimacy as well as on

hormonal factors. Previous studies indicate that 20% to 30% of Hormonal
contraception users experience a reduction in sexual desire.
The goal of the study is to compare the frequency of sexual complaints
among the users of: LNG-UID AND ETO-IMPLANT.
31 women, divide in 2 groups: 17 women LNG-DIU, 14 women ETO-implant.
Patients that have completed 12 months.
Inclusion criteria:
Women in use of Eto- Implant or LNG –DIU there is at least 3 months.
At least 18 years old, stable heterosexual relation during at least 3 months, in
a heterosexual relationship, not smokers, did not have any other psychiatric
pathology.
Normal levels of FSH, LH, DHEA, TSH, Prolactin. Physiologic levels of
Testosterone.

Evaluation Protocol Follow up. It was in three months intervals.

Numeral Visual Scale,. McCoy Sexual Scale, . Psychological General Well-Being
Index (PGWB)
. Short Sexual Functioning Scale (SSFS) VWAG/WOG/IFSSS/2005 applied in
each three months during one year.
History and physical examination ,BMI (body mass index) , Endometrial
evaluation by transvaginal ultrasound , (3º/5º day. Endometrial measure until
5mm.) .Lab: Blood (TBC) Coagulation, Glycemia, Triglycerides, Total cholesterol,
Urea, Creatinine, TSH, FSH, LH, Prolactin, Testosterone.

RESULTS :
10 women (32,2%) were multiparous
11 (35,4%) had concurrent medical conditions; all of them in medical supervision treatment.
LNG 88% had completed 12 months.
ETO 60.8% completed 12 months. The most common reason causing the retreat need was bleeding irregularity.
Depressive symptoms:
LNG group: Average depressive symptoms at first evaluation 17, 6%., average depressive symptoms at 3rd,
6th and 9th evaluation acres group to 21%.
ETO group: Average depressive symptoms at first evaluation 21, 4%, average depressive symptoms at 3rd,
6th and 9th evaluation acres to 26%.
Comparison: Eto implants versus LNG-UID.
LNG - IUD:
2 LNG insertions were performed under general anesthesia.
Bigger incidence of acne and breast pain.
Bigger amenorrhea indexes.
About the ability of progestin to produce negative mood 58% classified as none mood negative effects.
At 3rd, 6th and 9th evaluation average of depressive symptoms acres in the two groups.
LNG IUD group shown smaller acres percentage. (4%)
LNG IUD group shown the best performance, having less incidence in changes at sexual behavior.
When the changes happen this group had a smaller incidence in the sexual behavior negative changes as
arousal, desire's decrees ,
orgasm decrees as well.
This group also shown less number of patients complains of Sexual Wish Decreased and less desire for
sexual activities.
ETO_IMPLANT:
Higher incidence: In spotting, irregular bleeding, weight gain and migraine.
About the ability of progestin to produce negative mood 37% classified as none mood negative effects.
At 3rd, 6th and 9th evaluation average of depressive symptoms acres in both groups.
Eto-Implant group shown bigger acres on depressive symptoms percentage.
Female sexual dysfunction is a complex problem with multiple overlapping etiologies.
Hormones play an important role in healthy female sexual function
Sexual dysfunction: COMPARATIVE STUDY in LNG-UID and ETO-Implant users.
G.Grazziotin¹.
¹Tancredo Neves Medical Center, Mato Grosso, Brazil

Sexual desire depends on mood and motivation to sexual intimacy as well as on

hormonal factors. Previous studies indicate that 20% to 30% of Hormonal
contraception users experience a reduction in sexual desire.
The goal of the study is to compare the frequency of sexual complaints
among the users of: LNG-UID AND ETO-IMPLANT.
31 women, divide in 2 groups: 17 women LNG-DIU, 14 women ETO-implant.
Patients that have completed 12 months.
Inclusion criteria:
Women in use of Eto- Implant or LNG –DIU there is at least 3 months.
At least 18 years old, stable heterosexual relation during at least 3 months, in
a heterosexual relationship, not smokers, did not have any other psychiatric
pathology.
Normal levels of FSH, LH, DHEA, TSH, Prolactin. Physiologic levels of
Testosterone.

Evaluation Protocol Follow up. It was in three months intervals.

Numeral Visual Scale,. McCoy Sexual Scale, . Psychological General Well-Being
Index (PGWB)
. Short Sexual Functioning Scale (SSFS) VWAG/WOG/IFSSS/2005 applied in
each three months during one year.
History and physical examination ,BMI (body mass index) , Endometrial
evaluation by transvaginal ultrasound , (3º/5º day. Endometrial measure until
5mm.) .Lab: Blood (TBC) Coagulation, Glycemia, Triglycerides, Total cholesterol,
Urea, Creatinine, TSH, FSH, LH, Prolactin, Testosterone.
RESULTS :
10 women (32,2%) were multiparous
11 (35,4%) had concurrent medical conditions; all of them in medical supervision treatment.
LNG 88% had completed 12 months.
ETO 60.8% completed 12 months. The most common reason causing the retreat need was bleeding irregularity.
Depressive symptoms:
LNG group: Average depressive symptoms at first evaluation 17, 6%., average depressive symptoms at 3rd,
6th and 9th evaluation acres group to 21%.
ETO group: Average depressive symptoms at first evaluation 21, 4%, average depressive symptoms at 3rd,
6th and 9th evaluation acres to 26%.
Comparison: Eto implants versus LNG-UID.

LNG - IUD:
2 LNG insertions were performed under general anesthesia.
Bigger incidence of acne and breast pain.
Bigger amenorrhea indexes.
About the ability of progestin to produce negative mood 58% classified as none mood negative effects.
At 3rd, 6th and 9th evaluation average of depressive symptoms acres in the two groups.
LNG IUD group shown smaller acres percentage. (4%)
LNG IUD group shown the best performance, having less incidence in changes at sexual behavior.
When the changes happen this group had a smaller incidence in the sexual behavior negative changes as
arousal, desire's decrees ,
orgasm decrees as well.
This group also shown less number of patients complains of Sexual Wish Decreased and less desire for
sexual activities.

ETO_IMPLANT:
Higher incidence: In spotting, irregular bleeding, weight gain and migraine.
About the ability of progestin to produce negative mood 37% classified as none mood negative effects.
At 3rd, 6th and 9th evaluation average of depressive symptoms acres in both groups.
Eto-Implant group shown bigger acres on depressive symptoms percentage.
Female sexual dysfunction is a complex problem with multiple overlapping etiologies.
Hormones play an important role in healthy female sexual function